StockCIK 1674930

Fulgent Genetics, Inc. (FLGT): Insider Trades and Fund Holdings

In the past 12 months, Fulgent Genetics, Inc. insiders reported 0 open-market purchases worth $0 and 4 sales worth $117K; 0 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$117KSold by insiders, 12 months

0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 3, 2026.

Recent FLGT insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 3	Sep 2	Jian XieCOO	COO	▼ SELL	2,127	19.66	$42K	−0.6%	Form 4 ↗
Sep 3	Sep 2	Hanlin GaoChief Scientific Officer	Chief Scientific Officer	▼ SELL	1,673	19.66	$33K	−0.2%	Form 4 ↗
Aug 28	Aug 27	Jian XieCOO	COO	▼ SELL	1,193	19.91	$24K	−0.3%	Form 4 ↗
Aug 28	Aug 27	Hanlin GaoChief Scientific Officer	Chief Scientific Officer	▼ SELL	939	19.91	$19K	−0.1%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Jian Xie	COO	0	$0	2	$66K	Sep 3, 2026
Hanlin Gao	Chief Scientific Officer	0	$0	2	$52K	Sep 3, 2026

Tracked funds that report FLGT

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	0	$0	0.00%	▼ Sold out

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →